{"ticker": {"uuid": "19a23dd6-52dc-499f-86a0-baf374fc906a", "symbol": "CYAD", "name": "Celyad Oncology SA", "exchange": "BRU", "country": "BE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Celyad Oncology raises \u20ac500,000 from Fortress Investment Group By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPOFhMWEhXamkyNkFVRzN0em12MTQtTTJETmtRcFBhVTZVdHBEZzB0QUZwX05QSU5UelUtLXc1Z0UtejZZa295bXUzSnNuUHZBaWRFSFplQnN4eDdMTUcyWmhBZGpMaUZ4RjJRLWtjdHFIU1R2SmNiMURfZ0d3OXZLcko3enZ3SWVEZnFvcDdTaFplenVqVjl3NmdPc0ZvUWkyMUFTcmJWV3BlOGpsVk90S0phMTNYY3NxUkZmcXhB?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T16:58:58+00:00", "published_display": "14 Jul 2026 16:58", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Celyad Oncology Announces \u20ac500,000 Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNdlU0aUtIcGVzY3lWekF0UUlZVGc1cVhTMmFvUGl1WGNONTA0Mm5jN2dra0U1WGFPSUVsNFlUbkJ1bFhWZkwzQ0VHZ2w4aE51dEppN3BfTEpTbFRNUkVsNXp4LVBEb05nR0JaWEgxOEUyWlBCQ21TV0dMaTA2Z2FGbU80aDh0akVkZ1djRkZRcGFXcG1WZmdRUUZQalVLVTlsLVdhMUczbmljSUxmdDUtRkhrYUxkMDA?oc=5", "source_name": "Business Wire", "published_at": "2026-07-14T07:32:00+00:00", "published_display": "14 Jul 2026 07:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fortress Expected to Hold 68.75% of Celyad Voting Rights", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPUlhYWWk3UXh0bnZZank1dGJjU3I0WmRFc29qMUlsYVZvdko0eEUxV3V4Uy1YdHhJLVdNMDJ4WXI2MWlFTW1QcTNxeU1jZXM5eGNnZG15VlR1dlVZc294TzBsNHJGc0d5ZmhGZHNmeVFZSU83ZG83WDJkbWstbE9vLWttWG52eFgyQmo4ZlVIS0NRaUFQd0NUVlNxSFM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T07:32:00+00:00", "published_display": "14 Jul 2026 07:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Celyad Oncology Announces the Sale of C-CATHez \u00ae Catheter", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQSDZzRmdIYlBQZFQ2TDN5aENGdDNFd0ZjeG9UbUlMeUoxa1Z3NndYWk5BRkhqZ0gyckVGYUhRQUJ1UFZnNm1jV0VPaUlZaHdVS1d5UDBIS0RPdkRLRTdjbnRrWHhHU0ZpZmR4c2ZpbVk1VlB4TlBwendnVjU1Z3hjVWhXWng2Yk93eTBqU2djdXdNOXp4Umt0eXg1bThMcE53TlNfM1hjb0FXOTFHV1pkeXlB?oc=5", "source_name": "Business Wire", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Shutdown: Celyad Oncology Ends CAR-T Research Program, Pivots to IP Licensing Amid Cash Crunch", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOb01wMFQ4ZExMNGJLMFo5N0h0V25vUFdwa0dKSFNXODRCQl9KQkhnakNERkJFSGtLdjRJSG45VFdVS3VIQ01Gd09GMGM3Qkh4bTVaOTNHX3V2bHEzNkx5bmNveEtnX2V2dHpMQUhzQ3lWVmljbW9fdjRlX2RSWm9wcEhCWjV0VTNuaXBDbFo5TEQ0MGQ5VWc5cGRYVTZXbmh3ZkNuNjN3?oc=5", "source_name": "Stock Titan", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "By dropping remaining 'off-the-shelf' CAR-T, Celyad closes clinical pipeline to complete R&D pivot", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQTkJhRHI0ak1Oa1BoMm9IOWxMRjV4TEVjVjhQS2d1TUQ5UVY5cXF0dGlLUUxfZjEzOVR3TnAwTUhiMHBTcHJQaVpnNWtYNDVOcmhlZkdvR0ZFUnpNMFlvOTF6RkZYaDZXcmVvbzg0VmsyMGJSNHM1aFp6c0NNYkxSaGhOOHRNNDFrZF9JLXNmTXlGTUJzU0RUV2VocllRVS0yb21NcXFUazBJWjNqZ25BR3lqWHpVQmt6Qnc?oc=5", "source_name": "Fierce Biotech", "published_at": "2022-12-21T08:00:00+00:00", "published_display": "21 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Celyad Oncology raises \u20ac500,000 from Fortress Investment Group By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPOFhMWEhXamkyNkFVRzN0em12MTQtTTJETmtRcFBhVTZVdHBEZzB0QUZwX05QSU5UelUtLXc1Z0UtejZZa295bXUzSnNuUHZBaWRFSFplQnN4eDdMTUcyWmhBZGpMaUZ4RjJRLWtjdHFIU1R2SmNiMURfZ0d3OXZLcko3enZ3SWVEZnFvcDdTaFplenVqVjl3NmdPc0ZvUWkyMUFTcmJWV3BlOGpsVk90S0phMTNYY3NxUkZmcXhB?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T16:58:58+00:00", "published_display": "14 Jul 2026 16:58", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Celyad Oncology Announces \u20ac500,000 Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNdlU0aUtIcGVzY3lWekF0UUlZVGc1cVhTMmFvUGl1WGNONTA0Mm5jN2dra0U1WGFPSUVsNFlUbkJ1bFhWZkwzQ0VHZ2w4aE51dEppN3BfTEpTbFRNUkVsNXp4LVBEb05nR0JaWEgxOEUyWlBCQ21TV0dMaTA2Z2FGbU80aDh0akVkZ1djRkZRcGFXcG1WZmdRUUZQalVLVTlsLVdhMUczbmljSUxmdDUtRkhrYUxkMDA?oc=5", "source_name": "Business Wire", "published_at": "2026-07-14T07:32:00+00:00", "published_display": "14 Jul 2026 07:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fortress Expected to Hold 68.75% of Celyad Voting Rights", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPUlhYWWk3UXh0bnZZank1dGJjU3I0WmRFc29qMUlsYVZvdko0eEUxV3V4Uy1YdHhJLVdNMDJ4WXI2MWlFTW1QcTNxeU1jZXM5eGNnZG15VlR1dlVZc294TzBsNHJGc0d5ZmhGZHNmeVFZSU83ZG83WDJkbWstbE9vLWttWG52eFgyQmo4ZlVIS0NRaUFQd0NUVlNxSFM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T07:32:00+00:00", "published_display": "14 Jul 2026 07:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Celyad Oncology Announces the Sale of C-CATHez \u00ae Catheter", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQSDZzRmdIYlBQZFQ2TDN5aENGdDNFd0ZjeG9UbUlMeUoxa1Z3NndYWk5BRkhqZ0gyckVGYUhRQUJ1UFZnNm1jV0VPaUlZaHdVS1d5UDBIS0RPdkRLRTdjbnRrWHhHU0ZpZmR4c2ZpbVk1VlB4TlBwendnVjU1Z3hjVWhXWng2Yk93eTBqU2djdXdNOXp4Umt0eXg1bThMcE53TlNfM1hjb0FXOTFHV1pkeXlB?oc=5", "source_name": "Business Wire", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Shutdown: Celyad Oncology Ends CAR-T Research Program, Pivots to IP Licensing Amid Cash Crunch", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOb01wMFQ4ZExMNGJLMFo5N0h0V25vUFdwa0dKSFNXODRCQl9KQkhnakNERkJFSGtLdjRJSG45VFdVS3VIQ01Gd09GMGM3Qkh4bTVaOTNHX3V2bHEzNkx5bmNveEtnX2V2dHpMQUhzQ3lWVmljbW9fdjRlX2RSWm9wcEhCWjV0VTNuaXBDbFo5TEQ0MGQ5VWc5cGRYVTZXbmh3ZkNuNjN3?oc=5", "source_name": "Stock Titan", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "By dropping remaining 'off-the-shelf' CAR-T, Celyad closes clinical pipeline to complete R&D pivot", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQTkJhRHI0ak1Oa1BoMm9IOWxMRjV4TEVjVjhQS2d1TUQ5UVY5cXF0dGlLUUxfZjEzOVR3TnAwTUhiMHBTcHJQaVpnNWtYNDVOcmhlZkdvR0ZFUnpNMFlvOTF6RkZYaDZXcmVvbzg0VmsyMGJSNHM1aFp6c0NNYkxSaGhOOHRNNDFrZF9JLXNmTXlGTUJzU0RUV2VocllRVS0yb21NcXFUazBJWjNqZ25BR3lqWHpVQmt6Qnc?oc=5", "source_name": "Fierce Biotech", "published_at": "2022-12-21T08:00:00+00:00", "published_display": "21 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 62, "total_relevant": 6, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 5, "score": 54, "total": 6, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.26, "latest_week": "2026-07-17", "one_week_move": 17.1, "four_week_move": 0.0, "twelve_week_move": -17.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.851508, "market_dynamics_buy_signal": false, "relative_strength": -13.217551, "fair_value_gap": -33.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.5056, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+17.1% over one week, +0.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Wire", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "Fierce Biotech", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+17.1% over one week, +0.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Celyad Oncology raises \u20ac500,000 from Fortress Investment Group By Investing.com"}], "updated_at": "2026-07-18T08:49:01.574815+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}